Jul 2, 2014 by Dave WilliamsonShould Dividend Investors Eject Abbott Laboratories Stock?World Cup fever spreads to dividend stock AbbVie
Jun 30, 2014 by Dave Williamson and Michael DouglassWhy Investors are Wrong about GileadIts a bull vs bear fight over the popular big biotech
Jun 30, 2014 by Dave Williamson and Michael DouglassPredicting Dendreon's Next CEO's FutureIts time to play Fool in the blank
Jun 30, 2014 by Dave Williamson and Michael Douglass2 Breakthrough Vaccines Command Investor FocusPfizer and Novartis file for approval
Jun 30, 2014 by Dave Williamson and Michael DouglassDanger Ahead for Investors in this $8 Billion BlockbusterSanofi prepares Eli Lilly's pending diabetes competition
Jun 30, 2014 by Dave Williamson and Michael DouglassThe Next Orphan Drug Multibagger and Future Obesity Champion?Zafgen's arrival on public markets shakes up the obesity drug war
Jun 30, 2014 by Dave Williamson and Michael DouglassThis COPD Investment Opportunity Isn't What It SeemsTheravance's new structure may surprise investors looking for a pure play.
Jun 29, 2014 by Dave WilliamsonShould Dividend Investors Eject Eli Lilly and Co?World Cup fever spreads to dividend stock Eli Lilly
Jun 29, 2014 by Dave Williamson and Michael DouglassMore Unbelievable Success for this Mega Blockbuster in WaitingNivolumab's ph3 trial was halted early and its good news for investors
Jun 29, 2014 by Dave Williamson and Michael DouglassLifting the Curtain on Healthcare's Most Expensive DrugsEverything investors need to know about orphan drugs
Jun 29, 2014 by Dave Williamson and Michael Douglass40% Pop: Is this Ground Breaking Biotech Still a Buy?Vertex soared last week on CF data, but have investors missed the boat?
Jun 28, 2014 by Dave Williamson and Michael DouglassTax-Fleeing Takeover Mania Surges ForwardBig pharma AbbVie is hoping to succeed where Pfizer failed.
Jun 27, 2014 by Dave WilliamsonShould Dividend Investors Eject Johnson & Johnson?World Cup fever spreads to dividend aristocrat J&J
Jun 27, 2014 by Dave WilliamsonShould Dividend Investors Eject Merck & Co., Inc?World cup mania heads to dividend stocks
Jun 26, 2014 by Dave WilliamsonBetter Stock Today Challenge: Gilead vs. Isis PharmaceuticalsIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 25, 2014 by Dave WilliamsonShould Dividend Investors Eject UnitedHealth Group Inc.?World Cup fever spreads to dividend stock UnitedHealth
Jun 25, 2014 by Dave WilliamsonShould Dividend Investors Eject Pfizer Inc?It's a dividend showdown, World Cup style!
Jun 24, 2014 by Dave WilliamsonShould Dividend Investors Eject AstraZeneca Stock?A World Cup Inspired take on healthcare's biggest dividend stocks
Jun 24, 2014 by Dave WilliamsonShould Dividend Investors Eject AbbVie Stock?World Cup fever spreads to dividend stock AbbVie
Jun 24, 2014 by Dave Williamson and Joel SouthBetter Stock Today Challenge: Gilead vs. Kinder Morgan PartnersIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
